References

Parren, P. W., T. W. Geisbert, T. Maruyama, P. B. Jahrling, and D. R. Burton. 2002. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J. Virol. 76:6408-6412
Guzman, M. G. and G. Kouri. 2002. Dengue: an update. Lancet Infect. Dis. JID. - 101130150. 2:33-42
Drosten, C., S. Gottig, S. Schilling, M. Asper, M. Panning, H. Schmitz, and S. Gunther. 2002. Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR. J. Clin. Microbiol. JID. - 7505564. 40:2323-2330
Alcon, S., A. Talarmin, M. Debruyne, A. Falconar, V. Deubel, and M. Flamand. 2002. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. JID. - 7505564. 40:376-381
Galeno, H., J. Mora, E. Villagra, J. Fernandez, J. Hernandez, G. J. Mertz, and E. Ramirez. 2002. First Human Isolate of Hantavirus (Andes virus) in the Americas. Emerg. Infect. Dis. 8:657-661
Roberts, A. and C. Kemp. 2001. Ebola and Marburg hemorrhagic fevers. J. Am. Acad. Nurse Pract. 13:291-292
Roberts, A. and C. Kemp. 2001. Infectious diseases of refugees and immigrants: dengue fever. J. Am. Acad. Nurse Pract. 13:243-245
Moran, G. J. 2002. Threats in bioterrorism. II: CDC category B and C agents. Emerg. Med. Clin. North Am. 20:311-330
Darling, R. G., C. L. Catlett, K. D. Huebner, and D. G. Jarrett. 2002. Threats in bioterrorism. I: CDC category A agents. Emerg. Med. Clin. North Am. 20:273-309
Berger, S. A. and I. Shapira. 2002. Hemorrhagic fevers and bioterror. Isr. Med. Assoc. J. 4:513-519
Pile, J. 2001. West Nile fever: here to stay and spreading. Cleve. Clin. J. Med. 68:553-560

Print page | Close window